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Abstract
Objectives—Among 11–12 year-old girls who received the human papillomavirus (HPV) 
vaccine, we explored, over the subsequent 30 months: 1) trajectories of knowledge about 
HPV/HPV vaccines and vaccine-related risk perceptions; 2) whether knowledge and risk 
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perceptions impacted sexual attitudes and sexual experience; and 3) whether mothers, clinicians, 
and media influenced girls’ risk perceptions, attitudes, and behavior.
Methods—Girls and mothers (n=25 dyads) completed separate, semi-structured interviews 
within 2 days of, and 6, 18, and 30 months after, their first HPV vaccine dose. Knowledge, risk 
perceptions related to HPV and other sexually transmitted infections (STIs), and attitudes about 
sexual behaviors were assessed. Sexual experience was assessed at girls’ 30 month interviews. 
Clinicians completed interviews at baseline. Transcribed interviews were analyzed using 
framework analysis.
Results—Girls’ baseline knowledge was poor but often improved with time. Most girls (n=18) 
developed accurate risk perceptions about HPV but only half (n=12) developed accurate risk 
perceptions about other STIs by 30 months. The vast majority of girls thought that safer sex was 
still important, regardless of knowledge, risk perceptions, or sexual experience. Girls whose HPV 
knowledge was high at baseline or increased over time tended to articulate accurate risk 
perceptions; those who were able to articulate accurate risk perceptions tended to report not 
having initiated sexual activity. Girls whose mothers demonstrated higher knowledge and/or 
communication about HPV vaccination tended to articulate accurate risk perceptions, whereas 
clinicians and media exposure did not appear to influence risk perceptions.
Conclusions—Higher knowledge about HPV vaccines among mothers and girls was linked with 
more accurate risk perceptions among girls. Clinicians may play an important role in providing 
education about HPV vaccines to mothers and girls.
Keywords
Adolescents; Human papillomavirus (HPV) vaccine; Knowledge; Sexual attitudes; Mothers; 
Clinicians
Introduction
Human papillomavirus (HPV) vaccines are a highly effective strategy for decreasing rates of 
HPV-associated disease.1–4 Despite recommendations for routine HPV vaccination,5,6 
recent studies demonstrate suboptimal vaccination rates among girls,7 which may be due to 
parents not accepting or clinicians not recommending HPV vaccines.8 Low vaccine 
acceptance and recommendation may be due to concerns held by some parents9,10 and 
physicians11,12 that vaccination may lead to inaccurate risk perceptions (such as girls 
believing themselves to be at lower risk for sexually transmitted infections [STIs] other than 
HPV after vaccination) and subsequent riskier sexual behaviors.
Although studies suggest that HPV vaccination does not lead to riskier sexual 
behaviors,13–16 little is known about the development of girls’ HPV vaccine-related risk 
perceptions and the association of risk perceptions with sexual attitudes and behaviors 
following vaccination. Few studies have examined girls in the target age group for 
vaccination or included data from their mothers and clinicians. Because risk perceptions 
about STIs may predict sexual behaviors,17 understanding how risk perceptions develop and 
change after vaccination may provide insight into how clinicians can help girls to develop or 
maintain accurate risk perceptions. Additionally, if risk perceptions do not change or are not 
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related to changes in sexual attitudes and behaviors after vaccination, this information may 
provide reassurance to parents and clinicians, leading to increased vaccine recommendation 
and uptake. Other factors that may influence risk perceptions and sexual attitudes after 
vaccination include girls’ knowledge about HPV and HPV vaccines; parent and clinician 
knowledge, attitudes, and communication with girls about HPV vaccines; and girls’ 
exposure to media coverage about HPV vaccines. Little is known about post-vaccination 
attitudes among girls in the target age range for HPV vaccination; such data are essential to 
provide the evidence base for large-scale survey studies to determine whether vaccination 
affects sexual behaviors.18 Therefore, the aims of this 30-month study were to use 
qualitative methods to describe the following, among a sample of 11–12 year-old girls 
receiving the HPV vaccine, their mothers and clinicians: 1) trajectories of girls’ knowledge 
about HPV and HPV vaccines and risk perceptions after vaccination; 2) the relationship 
between girls’ knowledge and risk perceptions; 3) the relationship between girls’ 
knowledge, risk perceptions, and subsequent sexual attitudes and experience; and 4) the 
relationship between maternal knowledge and communication about HPV vaccines, 
clinician communication about HPV vaccines, and media messages about HPV vaccines and 
girls’ risk perceptions, sexual attitudes, and behavior.
Methods
This qualitative study was conducted between 6/2008 and 11/2012. Using an interview 
guide consisting of open- and close-ended questions, a trained interviewer conducted 
individual, face-to-face, semi-structured interviews with 11–12 year-old girls, their mothers, 
and their clinicians. In accordance with recommendations for sampling in qualitative 
research, recruitment was terminated when thematic saturation was achieved.19,20 Thirty-
three girls, 32 mothers, and 19 clinicians were recruited from two suburban, private, 
pediatric practices and one urban, academic pediatric primary care practice. Girls and 
mothers completed interviews within 2 days of girls’ receiving their first HPV vaccine dose 
and 6, 18, and 30 months after the first dose. Included in this analysis are interviews with the 
25 girls who attended the 30 month visit and at least 3 of the 4 total visits. Of these, 21 girls 
completed all visits; 1 girl completed the baseline, 6 month, and 30 month visits; and 3 girls 
completed the baseline, 18 month, and 30 month visits. Each girl’s clinician completed one 
interview at baseline. Each interview with girls assessed knowledge about HPV and HPV 
vaccines, risk perceptions related to HPV and other STIs, attitudes about sexual behaviors, 
and perceived influence of mothers, clinicians, and media on risk perceptions. Risk 
perceptions were assessed by asking the girl whether she perceived that the vaccine 
decreased her risk of HPV and other STIs. Sexual attitudes were assessed by asking the girl 
whether her risk perceptions about HPV and other STIs would influence her decisions about 
sexual behaviors. Girls were asked about the content of maternal and clinician 
communication about HPV vaccines, the content of any consumed media related to HPV 
vaccines, and the perceived influence of these factors on the girls’ vaccine-related risk 
perceptions. During the 30 month interview, sexual experience was assessed by asking the 
girl if she had ever had sex. Interviews of mothers assessed knowledge about HPV/HPV 
vaccines, communication with the daughter about HPV vaccines, and perception of the 
daughter’s vaccine-related risk perceptions. Interviews of clinicians assessed HPV vaccine-
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related knowledge, attitudes, and communication with the girl and mother. The hospital 
institutional review board approved this research.
Recordings were transcribed by an independent transcriptionist. The interviewer’s field 
notes were added to transcripts before analysis. The qualitative data was systematically 
analyzed using Framework Analysis approach.21,22 Each investigator (TKM, LEW, JAK) 
read and coded the transcripts independently. The investigators met to develop consensus on 
coding and data interpretation. First, we assessed knowledge (number of vaccine doses 
required, what diseases vaccination may prevent), vaccine-related risk perceptions with 
respect to HPV and other STIs (i.e. beliefs about whether the vaccine protects against HPV 
and/or other STIs), and attitudes toward sexual behaviors for each girl at each visit. Accurate 
risk perceptions were defined as a girl reporting that she was more protected against HPV 
and not protected from other STIs after vaccination. Based on these analyses, we described 
three trajectories over the 30-month study period: adolescent knowledge (i.e. did knowledge 
increase, decrease, remain unchanged), vaccine-related risk perceptions with respect to HPV 
and STIs (i.e. did the accurateness of HPV-related and STI-related risk perceptions change), 
and sexual attitudes (i.e. perceived need to practice safer sexual behaviors). For each girl, we 
first categorized trajectories of knowledge into: i) high knowledge throughout; ii) knowledge 
improving over time; iii) low knowledge throughout; and iv) inconsistent knowledge 
(knowledge varied over time). HPV and STI risk perceptions were categorized into: i) 
inaccurate/inability to articulate risk perceptions; ii) consistently accurate over time; iii) 
increasingly accurate over time; and iv) inconsistent. Second, we assessed the relationship 
between adolescent knowledge and risk perceptions over time. Third, we assessed the 
relationship between knowledge, risk perceptions, and sexual attitudes and experience over 
time. Fourth, we explored whether maternal and clinician knowledge and attitudes, 
communication between girls, mothers, and clinicians (as reported by all three), and media 
exposure (as reported by girls) were related to girls’ knowledge, risk perceptions, and sexual 
attitudes. Mothers and clinicians were considered influential if similar themes were reported 
by the girl/mother or clinician/girl dyad, respectively. A conceptual model depicting the 
study findings was developed.
Results
Thirteen girls were recruited at suburban practices; 12 were recruited from the urban 
practice. All girls recruited from the suburban practices were white; all girls recruited from 
the urban practice were black. Findings related to 1) trajectories of knowledge and risk 
perceptions, 2) influence of knowledge on risk perceptions, 3) influence of knowledge and 
risk perceptions on sexual attitudes and experience, and 4) influence of mothers, clinicians, 
and media on girls’ knowledge, risk perceptions, and sexual attitudes are described below.
Trajectories of Knowledge and Risk Perceptions
Trajectories of HPV and HPV Vaccine Knowledge—Baseline knowledge was 
generally low, although some girls gained knowledge over time. Half of girls (12/25) 
demonstrated good or improving knowledge; half (13/25) demonstrated low or inconsistent 
knowledge. Nine of 13 suburban girls demonstrated good or improving knowledge as 
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compared to only 3 of 12 urban girls. Improvement in knowledge appeared to be related to 
education that the girl received outside of the clinical setting, such as education received 
from a parent or in school, as evidenced by the reports of many girls of little clinician 
communication about the vaccine. Key knowledge points that girls identified included: a) 
HPV is an STI, b) HPV is sexually transmitted, and c) the vaccine prevents cancer/cervical 
cancer. Several misperceptions about HPV and the vaccine were noted, including: a) the 
type of cancer that the vaccine prevents (e.g., erroneously reported as breast cancer); b) what 
STI the vaccine prevents (e.g., erroneously reported as HIV/AIDS); c) the vaccine is 
therapeutic; and d) how HPV is transmitted (e.g., erroneously reported to be through 
smoking).
Trajectories of Risk Perceptions—Most girls (18/25) had accurate or increasingly 
accurate HPV-related risk perceptions, while 7/25 girls had inconsistent or inaccurate risk 
perceptions or were unable to articulate risk perceptions. Eleven of 13 suburban girls had 
accurate HPV risk perceptions by the end of the study as compared to 7 of 12 urban girls. In 
contrast, half of girls (13/25) had inaccurate or inconsistent STI-related risk perceptions by 
the 30 month visit (“I think if you prevent HPV, you can prevent lesser diseases [STIs].”), 
and half of girls (12/25) had accurate STI-related risk perceptions (“I don’t think that it 
[HPV vaccine] stops the others [STIs] because… it only stops this [HPV]. It doesn’t stop the 
other ones.”) These proportions were similar in suburban and urban girls.
Influence of Knowledge on Risk Perceptions
Girls who demonstrated consistently high or improving knowledge tended to articulate 
accurate HPV-related risk perceptions. Girls with high knowledge tended to articulate 
accurate STI-related risk perceptions; in contrast, those with low knowledge tended to 
articulate inaccurate risk perceptions. As knowledge increased over time, risk perceptions 
often became more accurate.
Influence of Knowledge and Risk Perceptions on Sexual Attitudes and Behavior
Seven girls specifically linked knowledge about HPV and the vaccine with safer sexual 
behavior: “I also believe that STDs, not all you can get rid of. And this [HPV vaccine] is 
meant to prevent some. So I still think it’s [having sex is] a bad decision.” Many girls and 
mothers believed that vaccination and vaccine-related risk perceptions would not influence 
girls’ sexual behaviors; one girl reported, “I wouldn’t not use protection just because I got 
the shot.” Although 20 girls endorsed feeling safer having sex following vaccination, the 
vast majority of these girls (18/20) felt unsafe having unprotected sex (i.e. without a 
condom). Even girls with poor knowledge and inaccurate risk perceptions reported that safer 
sex was important. By the conclusion of the study, 6/25 girls had initiated sexual activity; all 
six of them endorsed a belief in safer sex. None of the sexually experienced girls 
demonstrated high/increasing knowledge and accurate/improving risk perceptions. In 
contrast, over 1/3 of sexually inexperienced girls demonstrated high/increasing knowledge 
and accurate/improving risk perceptions. Only two girls maintained high knowledge 
throughout the study; both girls had accurate risk perceptions, expressed the importance of 
safer sex, and were not sexually experienced.
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Influence of Mothers, Clinicians, and Media on Girls’ Knowledge, Risk Perceptions, and 
Sexual Attitudes
Influence of Mothers—Good maternal knowledge and/or communication, as reported by 
girls and mothers, were related to accurate risk perceptions among girls (14/25), while poor 
maternal knowledge and/or communication were related to inaccurate or poor articulation of 
risk perceptions (7/25). Vaccination was described as protective, not just because 
vaccination prevented HPV but also because of the educational opportunity provided by the 
vaccination visit: “It [Getting the vaccine] made her smarter about it [delaying sex]. And just 
in case she doesn’t wait, then she needs to do something to protect herself from things.” 
Vaccination was seen as an opportunity to provide sexual health education to the girl (n=3): 
“We had the sex talk… So it definitely gave me an opportunity whereas before I’m not sure 
I would have… I would’ve had the conversation with her, but it gave me an excuse to have 
it.” Only half of the sexually experienced girls (3/6) reported that their mothers influenced 
their risk perceptions; in contrast, all of the sexually inexperienced girls noted that 
communication with their mothers was influential to their risk perceptions.
Influence of Clinicians—In half of girls (12/25), poor clinician communication, as 
evidenced by both clinicians and girls reporting little clinician communication about the 
vaccine, appeared to influence the girl’s inability to articulate risk perceptions. Although 12 
girls reported that their clinician was influential in the formation of their risk perceptions, 
only 3 girls demonstrated evidence of this influence (i.e., girl recalled information imparted 
by the clinician and discussed this information when describing her risk perceptions).
Influence of Media—Only one girl reported that the media was influential. However, her 
media exposure consisted of information that was obtained from the clinician’s office and an 
online group of which the girl was a member. Another girl reported using the internet with 
her mother in order to learn more about the vaccine. No girl reported that television or 
commercial print media was influential in the formation of her risk perceptions.
The conceptual model is shown in the Figure, demonstrating the key relationships 
betweenthemes as described above.
Discussion
We examined trajectories of knowledge and risk perceptions, the impact of knowledge and 
risk perceptions on sexual attitudes and sexual experience, and the influence of mothers, 
clinicians, and media on risk perceptions and sexual attitudes among 11–12 year old girls 
who received the HPV vaccine. This is the first study, to our knowledge, to examine 
longitudinal changes in risk perceptions, sexual attitudes, and sexual experience among girls 
who are in the target age group for HPV vaccination, and one of the first to include data 
collected from mothers and clinicians. Overall, we did not find evidence that HPV 
vaccination led to changes in girls’ sexual attitudes or riskier sexual behaviors. On the 
contrary, we found that mothers and girls generally believed that vaccination would lead to 
safer sexual behaviors because of the education provided during the vaccination visit.
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Girls generally had poor knowledge and inaccurate risk perceptions at baseline, particularly 
with respect to perceived risk of STIs other than HPV. We found that girls with high 
knowledge tended to be able to articulate accurate risk perceptions, whereas girls with poor 
knowledge were unable to articulate accurate risk perceptions, implying that sufficient 
knowledge was important in the formation of accurate risk perceptions. We observed 
differences in knowledge and risk perceptions between suburban and urban girls, which may 
be due to differences in health literacy23,24 or girls not seeing a consistent provider at the 
urban practice.25,26 Our data suggest that high knowledge may be related to both accurate 
risk perceptions and not initiating sexual activity. However, the vast majority of girls, 
regardless of knowledge, risk perceptions, or sexual experience, reported that condom use 
during sex was important. Our findings are consistent with prior studies demonstrating poor 
HPV knowledge among girls27–31 and women.27,32–34 This poor knowledge, combined with 
our findings that better knowledge about HPV and HPV vaccines was linked with more 
accurate risk perceptions and sexual inexperience, suggests that clinicians, parents, and 
others are missing opportunities to educate girls and ensure the development of accurate risk 
perceptions and safer sexual behaviors.
Our findings suggest that receiving HPV vaccination is unlikely to change girls’ sexual 
attitudes. Almost all of the girls reported plans to practice safer sexual behaviors and 
reported feeling unsafe having unprotected sex after vaccination. Furthermore, in contrast to 
reports of parental concerns that vaccination may lead to changes in risk perceptions and 
riskier sexual behaviors, we found that most mothers believed that vaccinated girls would be 
less likely to practice riskier behaviors due to the education that girls received with 
vaccination. Some mothers even noted that they used the vaccination visit as an opportunity 
to talk about their family’s values related to sex and provide sexual health education to their 
daughter. In a prior study, nearly half of mothers who had talked to their daughters about the 
HPV vaccine reported that the vaccine discussion led to a discussion about sex.35 The 
results of this study, combined with those of previous studies,13–16,36 suggest that clinicians 
can reassure parents that HPV vaccination does not lead to riskier sexual attitudes and that in 
fact the vaccination visit can be utilized by clinicians to promote healthier sexual behaviors.
Most mothers seemed to be influential in the development of girls’ knowledge and risk 
perceptions. Girls whose mothers had higher knowledge about HPV and communicated with 
their daughters about HPV vaccines demonstrated higher knowledge and more accurate risk 
perceptions. The influence of mothers is likely in part due to the sustained exposure that 
girls have to their mothers’ communication about sexual health and values.37 Because 
parents influence their children’s sexual attitudes and behaviors, clinicians should provide 
accurate information and resources to parents about sexual health38 so that parents can 
educate their children. Encouraging mothers to discuss safer sexual behaviors and convey 
their values to their daughters may lead to increased knowledge and development of 
accurate risk perceptions among girls.
In this study clinicians did not appear to be very influential in shaping girls’ knowledge, risk 
perceptions, or sexual attitudes. Girls reported that little vaccine-related information was 
communicated to them at the vaccination visit, which may not differ from their experiences 
with other routine vaccines. Most girls gained knowledge about HPV and the vaccine over 
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time, but this appeared to be related to education received outside of the clinician’s office. 
Clinicians may have more impact on girls’ knowledge and risk perceptions by discussing 
HPV, the vaccine, and sexual health with girls, and repeating this information at multiple 
visits. These topics can be incorporated into clinicians’ ongoing discussions of sexuality and 
reproductive health with children, adolescents, and parents, as recommended by clinical 
guidelines.38
Girls reported that print and television media did not influence their knowledge or risk 
perceptions. Among girls who were shown a television advertisement for the HPV vaccine, 
very few recalled any key messages about HPV or the vaccine.29 However, one girl in our 
study reported that her participation in an online, interactive group was influential. Future 
studies should examine whether media other than print or television, such as the internet, 
could be tools to facilitate education of, and communication between, parents and 
adolescents.
This study is subject to several limitations. Apparent low baseline knowledge or inability to 
articulate risk perceptions among girls may have been related to discomfort or inexperience 
talking about these topics. Second, girls’ knowledge may have been inconsistent because 
girls may retain information immediately after the clinic visit; this knowledge may diminish 
over time.39 Third, some girls may have reported perceived need for safer sexual behaviors 
because safer sex is socially desirable. We attempted to minimize this by using open-ended 
questions and a non-judgmental approach. Finally, girls were asked directly about whether 
they perceived an influence of the media on their risk perceptions. Because girls may not be 
aware that they had been influenced by media, this may result in an underestimation of the 
impact of media on the development of risk perceptions among girls. A concern sometimes 
raised regarding qualitative studies is that the findings are not generalizable. However, the 
goal of qualitative research is not to generate generalizable results but instead to gain an in-
depth understanding of a phenomenon or an experience - in this study, risk perceptions, 
sexual attitudes, and sexual behaviors after HPV vaccination.
Conclusions
Among 11–12 year-old girls who received the HPV vaccine, the vast majority thought that 
safer sex was still important, regardless of knowledge, risk perceptions, or sexual 
experience. Because better knowledge among girls and mothers was linked with girls having 
accurate risk perceptions, clinicians should provide education to girls and their mothers 
about HPV and the vaccine, which may lead to the development of accurate long-term risk 
perceptions among girls and reinforcement of girls’ decisions to practice safer sexual 
behaviors.
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Highlights
1. Girls with higher HPV and HPV vaccine knowledge had more accurate risk 
perceptions.
2. Girls with accurate risk perceptions had healthier sexual attitudes/behaviors.
3. Mothers’ knowledge and communication affected girls’ knowledge and risk 
perceptions.
4. The majority of girls reported that safer sex was still important.
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Figure 1. 
Conceptual Model: Relationships between Key Themes
1. HPV: Human papillomavirus
Accurate adolescent knowledge about HPV and the HPV vaccine is linked to appropriate 
vaccine-related risk perceptions. Both accurate knowledge about HPV and the HPV vaccine 
and appropriate vaccine-related risk perceptions were linked to lack of sexual experience. 
Maternal knowledge about HPV and the HPV vaccine, maternal communication, and other 
external influences (such as school) also influenced adolescent HPV and HPV vaccine 
knowledge and vaccine-related risk perceptions.
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